基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
No content for now
Research Interests
Papers共 21 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
E. P. Brodovskaya,K. Ya. Zaslavskaya, A. M. Al-Haj Ayub, I. A. Khutorskaya,A. V. Zaborovskii,L. A. Tararina, D. V. Unina, F. S. Sokolov,O. A. Radaeva,L. A. Balykova,N. A. Pyataev
Pharmaceutical Chemistry Journalno. 11 (2024): 1-5
Разработка и регистрация лекарственных средствno. 2 (2023): 146-153
A. S. Ametov,I. E. Shokhin,E. A. Rogozhina, T. G. Bodrova, M. E. Nevretdinova,P. A. Bely,K. Ya Zaslavskaya, V. S. Scherbakova, D. V. Kurkin,K. N. Koryanova, E. S. Mishchenko, E. Yu Kesova,
PHARMACY & PHARMACOLOGY-FARMATSIYA I FARMAKOLOGIYAno. 4 (2023): 324-346
Alʹmanah Kliničeskoj Medicinyno. 2 (2023): 86-98
Биопрепараты: Профилактика, диагностика, лечениеno. 3 (2023): 290-299
Drug development & registrationno. 1 (2023): 215-226
A. S. Ametov,I. E. Shokhin,E. A. Rogozhina, T. G. Bodrova, M. E. Nevretdinova,P. A. Bely,K. Ya. Zaslavskaya, D. V. Kurkin,K. N. Koryanova, E. S. Mishchenko,S. M. Noskov
PHARMACY & PHARMACOLOGY-FARMATSIYA I FARMAKOLOGIYAno. 3 (2023): 255-276
Л. А. Балыкова,N. Pshenichnaya,Хадижат Омарова,Dmitry Pushkar,K. Ya. Zaslavskaya,D. N. Zemskov,А. В. Таганов,P. A. Bely, А.V. Gorelov,E. D. Kozlov,O. I. Shepeleva, В И Прекина,
Acta medica Eurasicapp.1-15, (2023)
L. A. Balykova,O. A. Radaeva,K. Ya. Zaslavskaya,A. V. Taganov,P. A. Bely, K. A. Zakharov, V. V. Popova,T. I. Chudinovskikh, S. V. Teplykh, I. V. Balaban, R. S. Kozlov, N. V. Kirichenko,
Разработка и регистрация лекарственных средствno. 3 (2023): 229-239
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn